Renal diseases associated with human immunodeficiency virus infection: Epidemiology, clinical course, and management

Clinical Infectious Diseases

Volumn 33, Issue 1, 2001, Pages 115-119

  Szczech, L A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PREDNISONE; PROTEINASE INHIBITOR;

CLINICAL FEATURE; DISEASE COURSE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE COMPLEX NEPHRITIS; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DISEASE; MORTALITY; NEGRO; NEPHROTIC SYNDROME; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VIRUS REPLICATION;

AIDS-ASSOCIATED NEPHROPATHY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-HIV AGENTS; HUMANS; PREDNISONE; RISK FACTORS;

EID: 0034992496     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/320893     Document Type: Review

References (43)

1. Are we missing an epidemic of HIV-associated nephropathy?
2. Survival of human immunodeficiency virus-infected patients on maintenance dialysis
3. Continuous ambulatory peritoneal dialysis and survival of HW-infected patients with ESRD
4. Predictors of survival in HIV-infected patients on hemodialysis
5. Outcome of HIV-infected patients on continuous ambulatory peritoneal dialysis
6. Update: Mortality attributable to HIV infection among persons aged 25-44 years: United States, 1991 and 1992
7. AIDS among racial/ethnic minorities: United States, 1993
8. Update: Trends in AIDS diagnosis and reporting under the expanded surveillance definition for adolescents and adults: United States, 1993
9. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter
10. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
11. Effect of HAART on HIV-associated nephropathy
12. HIV-associated nephropathy is a late, not early, manifestation of HW-1 infection
13. Acute and chronic renal disease in hospitalized patients
14. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome
15. The types of renal disease in the acquired immunodeficiency syndrome
16. Course and prognosis of human immunodeficiency virus-associated nephropathy
17. Rapid renal failure in AIDS-associated focal glomerulosclerosis
18. Renal diseases in patients with AIDS: Sonographic findings
19. Renal involvement in patients infected with HIV: Experience at San Francisco General Hospital
20. The clinical spectrum of renal disease associated with human immunodeficiency virus
21. Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy
22. Increasing incidence of human immunodeficiency virus-associated nephropathy at San Francisco General Hospital
23. AIDS-related glomerulopathy: Occurrence in specific risk groups
24. HIV-associated nephropathy: Outcome and prognosis factors
25. Acute and chronic renal disease in hospitalized patients
26. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome
27. Course and prognosis of human immunodeficiency virus-associated nephropathy
28. Zidovudine is beneficial in human immunodeficiency virus associated nephropathy
29. Protease inhibitors are associated with a slowed progression of HIV-related renal diseases
30. Predictors of proteinuria and renal failure among patients with HIV infection
31. Acute and chronic renal disease in hospitalized AIDS patients
32. Captopril and renal survival in patients with human immunodeficiency virus nephropathy
33. Zidovudine and nephropathy with human immunodeficiency virus (HIV) infection [letter]
34. Nephropathy associated with human immunodeficiency virus: A report of 11 cases including 6 treated with zidovudine
35. HIV-1-associated nephropathy and response to highly-active antiretroviral therapy
36. Protease inhibitor therapy for HIV infection: The effect on HIV-associated nephrotic syndrome
37. Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression
38. Effect of highly active antiretroviral treatment and prednisone in biopsy-proven HIV-associated (HIVAN) nephropathy
39. Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy
40. Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy